Secretory cell expansion with aging: risk for pelvic serous carcinogenesis. (Q38419814)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Secretory cell expansion with aging: risk for pelvic serous carcinogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Jie Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Yan Ning

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Zeng Yuan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Yiying Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Yue Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Bingbing Yuan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Janiel M Cragun

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Setsuko K Chambers

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Kenneth Hatch

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Beihua Kong

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Wenxin Zheng

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

20 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

555-560

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24060413%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Tubal origin of 'ovarian' low-grade serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

The distal fallopian tube: a new model for pelvic serous carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Intercepting pelvic cancer in the distal fallopian tube: theories and realities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

BRCA, the oviduct, and the space and time continuum of pelvic serous carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Challenges in the early diagnosis and staging of Fallopian-tube carcinomas associated with BRCA mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Serous carcinogenesis in the fallopian tube: a descriptive classification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

PAX genes: roles in development, pathophysiology, and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Pax8: a marker for carcinoma of Müllerian origin in serous effusions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

The oviduct and ovarian cancer: causality, clinical implications, and "targeted prevention"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Precursors to pelvic serous carcinoma and their clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

New insights into the pathogenesis of serous ovarian cancer and its clinical impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Ovarian cancer: etiology, risk factors, and epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018

Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.018